(Q34155014)

31 July 2017

title

Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss (English)

1 reference

31 July 2017

0 references

0 references

1 reference

C A Wijbrandts

1

1 reference

31 July 2017

R Klaasen

2

1 reference

31 July 2017

M G W Dijkgraaf

3

1 reference

31 July 2017

D M Gerlag

4

1 reference

31 July 2017

B L F van Eck-Smit

5

1 reference

31 July 2017

P P Tak

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

13 April 2008

1 reference

Annals of the Rheumatic Diseases

31 July 2017

published in

1 reference

31 July 2017

volume

68

1 reference

31 July 2017

issue

3

1 reference

31 July 2017

page(s)

373-376

1 reference

A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945478

Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945478

Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebo-controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945478

Increase in bone mineral density of patients with spondyloarthropathy treated with anti-tumour necrosis factor alpha.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945478

Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945478

Transgenic mice expressing soluble tumor necrosis factor-receptor are protected against bone loss caused by estrogen deficiency

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945478

Increase in bone mineral density of patients with rheumatoid arthritis treated with anti-TNF-alpha antibody: a prospective open-label pilot study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945478

Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years

28 October 2018

1 reference

12 December 2020

Early changes in bone metabolism in rheumatoid arthritis patients treated with infliximab

1 reference

12 December 2020

Vertebral deformities in rheumatoid arthritis: a comparison with population-based controls

1 reference

12 December 2020

Generalised bone loss in patients with early rheumatoid arthritis

1 reference

12 December 2020

ACR and EULAR improvement criteria have comparable validity in rheumatoid arthritis trials. American College of Rheumatology European League of Associations for Rheumatology

1 reference

12 December 2020

TNF-α antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis

1 reference

12 December 2020

Identifiers

DOI

10.1136/ARD.2008.091611

1 reference

31 July 2017

1 reference

31 July 2017

1 reference